Company
Products
Investor
Investor
Media Releases
Community Updates
News Coverage
Leadership
Connect
Close
CSE: MVMD
CSE: MVMD
Company
Products
Investor
Connect
Latest News
MOUNTAIN VALLEY MD AWARDED CANADIAN PATENT FOR ITS QUICKSOME™ TECHNOLOGY
January 14, 2021
Read More
MOUNTAIN VALLEY MD HOLDINGS ANNOUNCES APPLICATION FOR OTCQB LISTING IN U.S., PROVIDES UPDATE ON WARRANT EXERCISES
January 11, 2021
Read More
MOUNTAIN VALLEY MD COMPLETES STRATEGIC SALE OF SUBSIDIARY, FINALIZING QUICKSOME™ LICENSE AGREEMENT
December 29, 2020
Read More
MOUNTAIN VALLEY MD FILES FOR ACCELERATION OF PATENT EXAMINATION FOR SOLUBILIZED IVERMECTIN
December 24, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS OVERSUBSCRIBES STRATEGIC PRIVATE PLACEMENT OFFERING OF UNITS
December 22, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS ANNOUNCES STRATEGIC PRIVATE PLACEMENT OFFERING OF UNITS, APPOINTMENT OF ADVISOR BOARD MEMBERS, AND PROPOSED DEBT SETTLEMENT
December 14, 2020
Read More
MOUNTAIN VALLEY MD CONFIRMS 800% INCREASE IN IVERMECTIN ABSORPTION WITH SOLUBILIZATION TECHNOLOGY IN PRE-CLINICAL TRIAL
December 10, 2020
Read More
MOUNTAIN VALLEY MD SECURES QUICKSOME™ LICENSE AGREEMENT AND STRATEGIC SALE OF SUBSIDIARY
November 25, 2020
Read More
MOUNTAIN VALLEY MD FILES PATENT TO PROTECT SCIENCE ACHIEVEMENT IN SOLUBILIZATION OF IVERMECTIN WITHOUT ORGANIC SOLVENTS AND ITS APPLICATION TO COVID-19 AND OTHER THERAPIES
November 11, 2020
Read More
MOUNTAIN VALLEY MD PROVIDES SUCCESSFUL QUICKSOME™ SUBLINGUAL PRE-CLINICAL TRIAL DOSING UPDATE
October 2, 2020
Read More
LEADING VACCINE EXPERT JOINS MOUNTAIN VALLEY MD ADVISORY BOARD TO ADVANCE QUICKSOME™ COMMERCIALIZATION
August 25, 2020
Read More
MOUNTAIN VALLEY MD SECURES DISTRIBUTION RIGHTS FOR NEW AGRICULTURAL PLANT STIMULANT
August 7, 2020
Read More
MOUNTAIN VALLEY MD ANNOUNCES SUCCESSFUL COMPLEXATION OF IVERMECTIN DRUG IN QUICKSOME™ ORAL STRIP AND COMMENCEMENT OF PRE-CLINICAL TRIALS
August 6, 2020
Read More
U.S. FOOD AND DRUG ADMINISTRATION (FDA) POLIO LAB CONFIRMS MOUNTAIN VALLEY MD’S QUICKSOME™ TECHNOLOGY SUCCESSFULLY PRESERVES POLIO D ANTIGEN FOR VACCINES
July 31, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS’ SUBSIDIARY COMPLETES ACQUISITION OF COLOMBIAN CANNABIS LICENCE SUITE
July 28, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS INC. COMPLETES INTELLECTUAL PROPERTY ASSET TRANSFER, SOLIDIFIES QUICKSOME TECHNOLOGY
July 17, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS INC. ANNOUNCES NEW CFO, NEW BOARD MEMBER AND TRANSITION OF PREVIOUS CFO TO ADVISORY ROLE
May 4, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS INC. PROVIDES UPDATE ON INTELLECTUAL PROPERTY ASSETS, COMPLETES SHARES FOR DEBT TRANSACTION AND GRANT OF OPTIONS
March 17, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS INC. COMMENCES TRADING ON CSE UNDER TICKER “MVMD”
March 2, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS INC. ANNOUNCES APPROVAL OF CSE LISTING
February 26, 2020
Read More
MOUNTAIN VALLEY MD HOLDINGS INC. COMPLETES REVERSE TAKEOVER TRANSACTION
February 24, 2020
Read More
Scroll for more.
See All Media Releases
Contact Us
Follow Us
Contact
Connect with Us.
Contact Us.
(647) 725-9755
info@mountainvalleymd.com
Head Office.
260 Edgeley Blvd. - Unit 4
Concord, Ontario, Canada
L4K 3Y4
Subscribe for Updates
Stay plugged in on everything Mountain Valley MD.
THANK YOU FOR YOUR INTEREST IN OUR STORY.
Please check your inbox to confirm your subscription.
Oops! Something went wrong while submitting the form.
*By Clicking "Sign Up" You agree to Mountain Valley MD's
Privacy Policy
Subscribe